Cann Group Limited (FRA:CVJ)

Market Cap	4.77M -36.2%
Revenue (ttm)	6.42M -27.1%
Net Income	8.37M
EPS	0.01
Shares Out	n/a
PE Ratio	0.57
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	n/a
Open	0.0002
Previous Close	0.0002
Day's Range	0.0002 - 0.0002
52-Week Range	0.0002 - 0.0130
Beta	n/a
RSI	48.14
Earnings Date	May 28, 2026

About Cann Group

Cann Group Limited, together with its subsidiaries, engages in the breeding, cultivation, manufacture, and sale of medicinal cannabis in Australia and Europe. Its product portfolio includes the Satipharm delivery system for cannabinoids. The company was founded in 2014 and is based in Mildura, Australia.

• Industry: Pharmaceutical Preparations
• Founded: 2014
• Country: Australia
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: CVJ

Financial Performance

In fiscal year 2025, Cann Group's revenue was 13.25 million, a decrease of -27.81% compared to the previous year's 18.36 million. Losses were -22.35 million, -56.39% less than in 2024.

Financial numbers in AUD